CClinicalTrials.gg
Active, not recruitingNCT02917876PredictorsUpdated Nov 22, 2024

Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy

An observational study in Obstructive Sleep Apnea, Pregnancy and Obesity, sponsored by The Miriam Hospital. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-22.

Sponsored by The Miriam Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
450
Ages
18 Years and older
Sex
Female
01

Study summary

This study seeks to understand the physical, physiologic and biologic features that predispose a woman to the development of obstructive sleep apnea once they are exposed to the cardiopulmonary and metabolic physiological changes of pregnancy. Knowing these specific predictive factors can help identify a population at risk and guide clinicians to develop suitable targeting screening strategies.

Read the detailed description

Patients will be recruited from multiple community and hospital-based practices that care for pregnant women. Subjects will have:

  1. measurements of body composition
  2. anthropometric measures
  3. sleep and mood questionnaires
  4. Home sleep studies
  5. blood testing for biological markers
  6. salivary testing for hormonal markers
  7. pulmonary function tests and upper airway patency measurements

Women without sleep apnea at enrollment will then be followed longitudinally for the development of obstructive sleep apnea during pregnancy with repeat assessment during their third trimester. Women diagnosed with sleep apnea at enrollment will have no further assessment in late pregnancy.

Monetary incentives will also be issued at data collection points. Subjects will receive small gift incentives such as baby-related items.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Pregnancy
  • Obesity
  • Sleep

Keywords

  • Obstructive Sleep Apnea
  • Pregnancy
  • Obesity
  • Fluid shifts
  • Body composition
  • Sleep
03

In context

Apnea

1,423 studies on the registry are indexed under Apnea; 160 are open to participants now.

This study's planned enrollment of 450 is above the median of 106 across 386 observational studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

The Miriam Hospital is the lead sponsor of 178 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women, 18 years or older, at less than 13 completed weeks of gestation and who have a BMI that is greater than 30 kg/m2 at recruitment.

Inclusion criteria

  • \<13 completed weeks of gestation
  • BMI >30 kg/m2 at recruitment
  • >18 years of age
  • Ability to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Unable to meet inclusion criteria
  • Twin pregnancies
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
450 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Characteristics of participants who develop obstructive sleep apnea defined as an apnea hypopnea index >5 events per hour

    The study will develop a model of biologic, physiologic and anthropometric measures that predict the development of obstructive sleep apnea apnea later in pregnancy compared to baseline in early pregnancy.

    Time frame: Up to 40 weeks

07

Study locations

1 site
  • The Miriam Hospital
    Providence, Rhode Island 02904, United States
08

References and documents

Publications

  • Sanapo L, Bublitz MH, Bai A, Mehta N, Messerlian GM, Catalano P, Bourjeily G. Association between sleep disordered breathing in early pregnancy and glucose metabolism. Sleep. 2022 Apr 11;45(4):zsab281. doi: 10.1093/sleep/zsab281. PubMed 34999843 ↗

Individual participant data

Plan to share: Yes — De-identified data for primary and secondary outcome measures will be made available.

Supporting information: Study protocol, Sap, Icf, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02917876
Lead sponsor
The Miriam Hospital
Collaborators
Brown University, Rhode Island Hospital, Women and Infants Hospital of Rhode Island
Responsible party
Ghada Bourjeily (Associate Professor of Medicine, The Miriam Hospital) — Principal investigator
First posted
Sep 28, 2016
Start date
Nov 2016
Primary completion
Dec 30, 2023
Completion
May 1, 2025 (estimated)
Last update
Nov 22, 2024

Study contacts

Ghada Bourjeily, MD
principal investigator · The Miriam Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion